Eli Lilly announced today that it will acquire Verve Therapeutics for up to $1.3 billion to develop single-dose base-editing treatments for people...
Using CRISPR-Cas9 screens, researchers in the United States, Belgium and China have identified NR2F2 as a key driver of endocrine resistance in breast...
CRISPR-associated transposons (CASTs) are emerging as powerful tools for genome engineering, offering the ability to insert large DNA fragments...
Researchers in China report that orally-administered CRISPR-Cas9-loaded nanoparticles, designed to target the mitochondrial chaperone TRAP1, overcome...
A new review in Gut explores how advances in RNA-based therapies may impact the treatment of liver metabolic diseases with unprecedented precision and...
Researchers in China report that targeting mutant HTT RNA with CRISPR/CasRx reduces the expression of diseased huntingtin protein and improves...
Scientists engineered ultrasound-controlled CRISPR tools that can precisely edit genes deep within tissues, demonstrating successful gene regulation...
Researchers in Korea report that large DNA deletions occur during DNA repair at a much lower frequency for base editors and prime editors than for...
